RoActemra

BIOLOGICAL3 trials

Sponsors

Karolinska Institutet, Assistance Publique - Hôpitaux de Paris

Conditions

Autoimmune DiseasesInflammatory DiseaseRheumatoid Arthritis

Phase 2

Personalized Therapies in Inflammatory Complex Disease

RecruitingNCT03651518

Assistance Publique - Hôpitaux de ParisAutoimmune Diseases, Inflammatory Disease

Start: 2020-10-20End: 2025-11-30Target: 32Updated: 2025-11-20

Phase 4

Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction

Karolinska InstitutetRheumatoid Arthritis

Start: 2012-12-14End: 2023-12-31Updated: 2022-07-08

Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity

Karolinska InstitutetRheumatoid Arthritis

Start: 2015-02-03End: 2023-12-31Updated: 2022-07-08

Related Papers

Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.

2026-04-01

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial

RMD Open2025-06-01

OP0327 TAPERING AND DISCONTINUATION OF GLUCOCORTICOIDS IN EARLY RHEUMATOID ARTHRITIS: THE RISK OF FLARE

Annals of the Rheumatic Diseases2025-06-01

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.

2024-11-145 citations

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

RMD Open2024-04-0118 citations

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.

2024-03-051 citations

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.

2023-07-0929 citations

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.

2021-07-1311 citations

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

BMJ2020-12-02108 citations

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.

2017-04-0426 citations